Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
mutual funds
hdfc pharma and healthcare fund directgrowth
HDFC Mutual Fund

HDFC Pharma And Healthcare Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return IndexCheck Portfolio Overlap →
NAV: ₹20.8-0.11%
22 Oct 2026
1 Week returns: -2.01 %
Category rank: 12/24
1 Month returns: -8.34 %
Category rank: 12/24
1 Year CAGR: 16.56 %
Category rank: 1/21
3 Years CAGR: 27.69 %
Category rank: 1/12
5 Years CAGR: -
Category rank: -
52 week high/low
₹16.83
₹22.89
AUM
3501.37
Expense Ratio
1.05
Inception
1696896.00
P/E
48.70
P/B
6.30
Max Drawdown
-0.15
Return 1M
-8.34
Return 1Y
16.56
Return 3Y
27.69
Return 5Y
-
Alpha
-
Sharpe
-

Key Talking Points

Important talking points about the scheme's performance, expense ratio and other factors — grouped by positive, negative, and neutral stance.
Positive
3-year performance has been in the top 25th percentile

3-year CAGR of 27.69% is in the top 25th percentile in its category - Equity: Sectoral-Pharma

This is measured by percentile rank of the scheme in its category based on 3-year CAGR. Lower rank implies that scheme was a relative outperformer in its category

What is CAGR (3Y)?

Relatively low expense ratio

Expense ratio of the scheme (1.05%) is lower than average expense ratio of the category (1.79%), excluding index funds and ETFs

This measures the relative expense of the scheme with respect to average expense ratio of the category. Investors should always prefer schemes with lower expense, everything else remaining the same

What is Expense ratio?

Negative
Not enough talking points with negative stance
Neutral
Not enough talking points with neutral stance

Scheme Overview

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Scheme Category Overview →

Plan Variants

HDFC Pharma And Healthcare Fund Direct-IDCW
Plan
IDCW
Payout
Irregular

Fund Managers

Dhruv Muchhal
Since: 14 Sep 2023
View details
Education
Mr. Dhruv has done B.Com, CA and CFA
Past Experience
Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells
Funds managed (42)
1.HDFC Value Fund22 Jun 2023 – Present
2.HDFC Childrens Fund22 Jun 2023 – Present
3.HDFC Overnight Fund22 Jun 2023 – Present
4.HDFC Money Market Fund22 Jun 2023 – Present
5.HDFC Ultra Short to Short Term Fund22 Jun 2023 – Present
6.HDFC Focused Fund22 Jun 2023 – Present
7.HDFC Flexi Cap Fund22 Jun 2023 – Present
8.HDFC Floating Interest Rates Fund22 Jun 2023 – Present
9.HDFC Balanced Advantage Fund22 Jun 2023 – Present
10.HDFC Medium Term Fund22 Jun 2023 – Present
11.HDFC Dynamic Term Fund22 Jun 2023 – Present
12.HDFC Medium to Long Term Fund22 Jun 2023 – Present
13.HDFC Infrastructure Fund22 Jun 2023 – Present
14.HDFC Corporate Bond Fund22 Jun 2023 – Present
15.HDFC Mid Cap Fund22 Jun 2023 – Present
16.HDFC Equity Savings Fund22 Jun 2023 – Present
17.HDFC Multi Asset Allocation Fund22 Jun 2023 – Present
18.HDFC Aggressive Hybrid Fund22 Jun 2023 – Present
19.HDFC Short Term Fund22 Jun 2023 – Present
20.HDFC ELSS - Tax Saver Fund22 Jun 2023 – Present
21.HDFC Large Cap Fund22 Jun 2023 – Present
22.HDFC Liquid Fund22 Jun 2023 – Present
23.HDFC Conservative Hybrid Fund22 Jun 2023 – Present
24.HDFC Small Cap Fund22 Jun 2023 – Present
25.HDFC Large & Mid Cap Fund22 Jun 2023 – Present
26.HDFC Credit Risk Fund22 Jun 2023 – Present
27.HDFC Banking and PSU Debt Fund22 Jun 2023 – Present
28.HDFC Arbitrage Fund22 Jun 2023 – Present
29.HDFC Housing Opportunities Fund22 Jun 2023 – Present
30.HDFC Ultra Short Term Fund22 Jun 2023 – Present
31.HDFC Banking & Financial Services Fund22 Jun 2023 – Present
32.HDFC Multi Cap Fund22 Jun 2023 – Present
33.HDFC Business Cycle Fund22 Jun 2023 – Present
34.HDFC Long Term Fund22 Jun 2023 – Present
35.HDFC MNC Fund22 Jun 2023 – Present
36.HDFC Defence Fund22 Jun 2023 – Present
37.HDFC Consumption Fund23 Jun 2023 – Present
38.HDFC Transportation and Logistics Fund28 Jul 2023 – Present
39.HDFC Technology Fund25 Aug 2023 – Present
40.HDFC Pharma And Healthcare Fund14 Sep 2023 – Present
41.HDFC Manufacturing Fund26 Apr 2024 – Present
42.HDFC Innovation Fund27 Jun 2025 – Present
Nikhil Mathur
Since: 14 Sep 2023
View details
Education
Mr. Mathur has done B.Tech and PGDM in Finance
Past Experience
Prior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY

Key Scheme Details

Inception
10 Oct 2023
Expense Ratio
1.05%
AUM
₹3,501.37 Cr
Lock in
No lock in
Taxation
Equity
Min. Investment
₹100
Min. Addl Investment
-
Min. SIP Investment
₹100
Exit load
Exit load of 1%, if redeemed within 30 days.

AMC Overview

HDFC Mutual Fund background and AUM insights, category-wise distribution and historical AUM growth.

AUM Analysis

AUM distribution as on date:
Sep 30, 2026
Total AUM: ₹ 9,34,076 Cr
Equity
₹ 4,95,158 Cr
Debt
₹ 2,25,801 Cr
Hybrid
₹ 1,81,492 Cr
Commodities
₹ 31,624 Cr
Dec 31, 2021Jan 31, 2022Feb 28, 2022Mar 31, 2022Apr 30, 2022May 31, 2022Jun 30, 2022Jul 31, 2022Aug 31, 2022Sep 30, 2022Oct 31, 2022Nov 30, 2022Dec 31, 2022Jan 31, 2023Feb 28, 2023Mar 31, 2023Apr 30, 2023May 31, 2023Jun 30, 2023Jul 31, 2023Aug 31, 2023Sep 30, 2023Oct 31, 2023Nov 30, 2023Dec 31, 2023Jan 31, 2024Feb 29, 2024Mar 31, 2024Apr 30, 2024May 31, 2024Jun 30, 2024Jul 31, 2024Aug 31, 2024Sep 30, 2024Oct 31, 2024Nov 30, 2024Dec 31, 2024Jan 31, 2025Feb 28, 2025Mar 31, 2025Apr 30, 2025May 31, 2025Jun 30, 2025Jul 31, 2025Aug 31, 2025Sep 30, 2025Oct 31, 2025Nov 30, 2025Dec 31, 2025Jan 31, 2026Feb 28, 2026Mar 31, 2026Apr 30, 2026May 31, 2026Jun 30, 2026Jul 31, 2026Aug 31, 2026Sep 30, 2026
equity1,38,058 Cr1,40,823 Cr1,34,428 Cr1,40,797 Cr1,41,923 Cr1,38,841 Cr1,34,450 Cr1,48,166 Cr1,55,466 Cr1,53,397 Cr1,61,039 Cr1,69,652 Cr1,67,359 Cr1,66,518 Cr1,65,968 Cr1,68,962 Cr1,77,506 Cr1,86,428 Cr1,99,449 Cr2,11,573 Cr2,16,940 Cr2,25,044 Cr2,23,472 Cr2,43,078 Cr2,63,998 Cr2,75,131 Cr2,83,083 Cr2,86,868 Cr3,01,853 Cr3,20,106 Cr3,49,004 Cr3,68,918 Cr3,76,708 Cr3,88,528 Cr3,75,735 Cr3,81,727 Cr3,82,189 Cr3,70,829 Cr3,48,060 Cr3,76,094 Cr3,92,310 Cr4,09,655 Cr4,28,325 Cr4,28,578 Cr4,28,355 Cr4,39,056 Cr4,61,609 Cr4,70,576 Cr4,72,766 Cr4,67,278 Cr4,75,791 Cr4,28,279 Cr4,74,682 Cr4,79,329 Cr4,96,515 Cr5,12,977 Cr5,21,093 Cr4,95,158 Cr
hybrid81,512 Cr83,562 Cr81,589 Cr83,422 Cr84,243 Cr83,462 Cr81,891 Cr86,612 Cr89,045 Cr87,444 Cr91,151 Cr93,400 Cr92,622 Cr92,201 Cr92,092 Cr92,924 Cr96,499 Cr98,709 Cr1,01,822 Cr1,06,766 Cr1,07,999 Cr1,11,789 Cr1,11,427 Cr1,17,909 Cr1,25,795 Cr1,31,737 Cr1,34,821 Cr1,36,201 Cr1,42,079 Cr1,45,937 Cr1,52,341 Cr1,59,691 Cr1,62,640 Cr1,64,282 Cr1,63,040 Cr1,64,281 Cr1,64,110 Cr1,62,829 Cr1,57,243 Cr1,64,177 Cr1,69,502 Cr1,74,815 Cr1,78,761 Cr1,77,840 Cr1,77,044 Cr1,79,936 Cr1,86,000 Cr1,88,577 Cr1,89,405 Cr1,87,900 Cr1,89,319 Cr1,74,548 Cr1,84,681 Cr1,83,464 Cr1,85,571 Cr1,88,661 Cr1,88,701 Cr1,81,492 Cr
debt2,16,228 Cr2,12,660 Cr2,09,028 Cr1,81,754 Cr1,86,794 Cr1,96,903 Cr1,85,839 Cr1,86,757 Cr1,90,677 Cr1,81,546 Cr1,84,288 Cr1,89,479 Cr1,88,655 Cr1,85,402 Cr1,84,802 Cr1,70,614 Cr1,95,020 Cr2,02,828 Cr1,95,861 Cr2,03,928 Cr2,00,621 Cr1,86,571 Cr1,94,084 Cr1,90,479 Cr1,86,738 Cr1,95,995 Cr2,05,788 Cr1,85,020 Cr2,08,477 Cr2,10,041 Cr2,06,917 Cr2,23,135 Cr2,27,038 Cr2,18,310 Cr2,35,729 Cr2,41,438 Cr2,32,425 Cr2,39,435 Cr2,37,981 Cr2,12,158 Cr2,47,928 Cr2,44,024 Cr2,47,459 Cr2,60,723 Cr2,57,048 Cr2,49,742 Cr2,56,954 Cr2,59,567 Cr2,45,459 Cr2,46,224 Cr2,54,254 Cr2,21,715 Cr2,46,797 Cr2,38,955 Cr2,32,577 Cr2,36,514 Cr2,43,713 Cr2,25,801 Cr
commodities2,924 Cr2,894 Cr3,057 Cr3,087 Cr3,135 Cr3,119 Cr3,176 Cr3,206 Cr3,158 Cr3,143 Cr3,102 Cr3,274 Cr3,427 Cr3,543 Cr3,419 Cr3,783 Cr3,806 Cr3,858 Cr3,751 Cr3,870 Cr3,890 Cr3,806 Cr4,120 Cr4,169 Cr4,212 Cr4,220 Cr4,263 Cr4,656 Cr5,004 Cr5,164 Cr5,276 Cr5,323 Cr5,794 Cr6,361 Cr7,015 Cr6,848 Cr6,982 Cr8,520 Cr9,052 Cr9,609 Cr10,172 Cr10,548 Cr11,158 Cr11,852 Cr12,748 Cr16,478 Cr18,872 Cr20,462 Cr24,562 Cr35,830 Cr32,956 Cr29,823 Cr30,888 Cr32,490 Cr29,582 Cr29,758 Cr32,730 Cr31,624 Cr
Total4,38,722 Cr4,39,939 Cr4,28,102 Cr4,09,060 Cr4,16,096 Cr4,22,325 Cr4,05,357 Cr4,24,741 Cr4,38,346 Cr4,25,530 Cr4,39,580 Cr4,55,805 Cr4,52,063 Cr4,47,665 Cr4,46,281 Cr4,36,283 Cr4,72,831 Cr4,91,823 Cr5,00,883 Cr5,26,137 Cr5,29,450 Cr5,27,210 Cr5,33,104 Cr5,55,635 Cr5,80,744 Cr6,07,083 Cr6,27,955 Cr6,12,746 Cr6,57,413 Cr6,81,249 Cr7,13,538 Cr7,57,067 Cr7,72,180 Cr7,77,481 Cr7,81,518 Cr7,94,294 Cr7,85,707 Cr7,81,614 Cr7,52,336 Cr7,62,038 Cr8,19,911 Cr8,39,042 Cr8,65,702 Cr8,78,993 Cr8,75,194 Cr8,85,212 Cr9,23,436 Cr9,39,182 Cr9,32,192 Cr9,37,232 Cr9,52,320 Cr8,54,364 Cr9,37,048 Cr9,34,238 Cr9,44,244 Cr9,67,910 Cr9,86,237 Cr9,34,076 Cr

AMC Details

AMC
HDFC Mutual Fund
CEO
Navneet Munot(Chief Executive Officer)
IRO
Sameer Seksaria
Trustee
HDFC Trustee Company Ltd
Address
"HDFC House", 2nd Floor,, H. T. Parekh Marg, 165-166, Backbay, Reclamation, Churchgate, Mumbai

Frequently Asked Questions

What is the current NAV of HDFC Pharma And Healthcare Fund Direct-Growth?
The current NAV of HDFC Pharma And Healthcare Fund Direct-Growth is ₹20.80 as of 21 Oct 2026. The NAV of a mutual fund reflects the per-unit market value of the fund's holdings and is updated at the end of every trading day.
What is the AUM of HDFC Pharma And Healthcare Fund Direct-Growth?
The AUM (Assets Under Management) of HDFC Pharma And Healthcare Fund Direct-Growth is ₹3,501.37 crore. AUM represents the total market value of assets the fund currently manages on behalf of its investors.
What is the expense ratio of HDFC Pharma And Healthcare Fund Direct-Growth?
The expense ratio of HDFC Pharma And Healthcare Fund Direct-Growth is 1.05% per annum. This is the annual fee charged by the fund house to manage your investment. A lower expense ratio means more of your returns stay with you — which is one reason direct plans have a lower expense ratio than regular plans.
Who is the fund manager of HDFC Pharma And Healthcare Fund Direct-Growth?
HDFC Pharma And Healthcare Fund Direct-Growth is managed by Dhruv Muchhal, Nikhil Mathur. You can check the full list of fund managers in the "Fund Manager" section above.
What is the benchmark of HDFC Pharma And Healthcare Fund Direct-Growth?
The benchmark of HDFC Pharma And Healthcare Fund Direct-Growth is BSE Healthcare Total Return Index. This is the index against which the fund's performance is measured. Consistently beating the benchmark over long periods is a key indicator of a fund manager's skill.
When was HDFC Pharma And Healthcare Fund Direct-Growth launched?
HDFC Pharma And Healthcare Fund Direct-Growth was launched on 10 Oct 2023. The fund has been in existence for 3 years. A longer track record gives investors more data to evaluate how the fund has performed across different market cycles.
What is the minimum investment in HDFC Pharma And Healthcare Fund Direct-Growth?
The minimum investment in HDFC Pharma And Healthcare Fund Direct-Growth is ₹100 for a lump sum and ₹100 per month for a SIP (Systematic Investment Plan). SIPs allow you to invest a fixed amount regularly, making it easier to build wealth over time without needing a large upfront amount.
What is the exit load on HDFC Pharma And Healthcare Fund Direct-Growth?
HDFC Pharma And Healthcare Fund Direct-Growth has an exit load — Exit load of 1%, if redeemed within 30 days.. Exit load is charged to discourage early withdrawals and protect long-term investors in the fund.
What category does HDFC Pharma And Healthcare Fund Direct-Growth belong to?
HDFC Pharma And Healthcare Fund Direct-Growth belongs to the Equity: Sectoral-Pharma category. You can view other funds in this category.